Home/ Supplements/ Vitamin K/ D3 125 mcg + K2 100 mcg

D3 125 mcg + K2 100 mcg

product on market Softgel Capsule Sports Research Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin D3 and K2 are frequently combined to support calcium absorption and bone health. Research provides strong evidence for their role in maintaining skeletal integrity and cardiovascular function. However, overall evidence coverage for this specific formulation remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for D3 125 mcg + K2 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Veggie Softgel(s)
Serving Size
60
Servings
Vitamin
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

VEGADELIGHT
125 mcg (625% DV)
100 mcg
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Coconut Tapioca Starch, Modified Glycerin Water, Purified Turmeric Olive Oil
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Adults take 1 veggie softgel daily with food, or as recommended by a qualified healthcare professional.

This product is intended for individuals who do not obtain the RDI through their daily diet.

Warnings & Precautions

Caution: Keep out of reach of children and pets.

Do not consume with other high dose Vitamin D supplements. Do not exceed recommended daily intake. Do not use if safety seal is damaged or missing.

Consult with a qualified healthcare professional prior to using this product especially if you are pregnant, nursing, have a diagnosed medical condition, or are taking a prescription medication (e.g., anticoagulants [coumadin/warfarin[).

Contains: Tree nuts (coconut).

Formulation Notes

Quality matters Third party tested cGMP compliant

Non GMO Project Verified nongmoproject.org Non-GMO Verified Gluten-free

Certified Vegan Vegan.org

Plant-based Supports bone & immune health

125mcg (5000 IU) D3 100mcg K2 D3 + K2 with coconut MCT

Vegan

Proudly manufactured in the USA with carefully selected ingredients of domestic and international origins. Lot number & best by date printed on bottom of bottle.

Additional Information

Non GMO Project Verified nongmoproject.org Certified Vegan Vegan.org

Store at room temperature, in a dry place. Protect from excessive heat, freezing, humidity and light.

HDPE Non BPA Please recycle Scan for more

@sportsresearch

Metadata

Product Details

UPC / SKU0 23249 01134 7
DSLD Entry Date2024-02-22
Product TypeVitamin
FormSoftgel Capsule
DSLD ID309609
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.